ArticleBMC cancer2020

Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.

Hironaga Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.